S Lozano-Esparza1, R López-Ridaura1, E Ortiz-Panozo1, C González-Villalpando1, C Aguilar-Salinas2, J E Hernández-Ávila1, M Hernández-Ávila3, M Lajous4. 1. Center for Population Health Research, National Institute of Public Health, Mexico City, Mexico. 2. Department of Endocrinology and Metabolism, Salvador Zubirán National Institute of Medical Sciences and Nutrition, Mexico City, Mexico. 3. Mexican Institute of Social Security (IMSS), Avenue Paseo de la Reforma 476, Juárez, 06600 Ciudad de México, CDMX, México. 4. Center for Population Health Research, National Institute of Public Health, Mexico City, Mexico; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: mlajous@insp.mx.
Abstract
AIMS: In Mexico City, the mortality rate among patients with diabetes appears to be four times that of people without diabetes. Our study aimed to refine analyses of the impact of diabetes on mortality in a large cohort of women from different areas in Mexico with healthcare insurance. METHODS: Our study followed 111,299 women with comprehensive healthcare coverage from the Mexican Teachers' Cohort. After a median follow-up of 7.8years, 5514 (5%) prevalent self-reported diabetes cases and 4023 incident cases were identified, while deaths were identified through employers' databases and next-of-kin reports, with dates and causes of death for 1121 women obtained from mortality databases. Hazard ratios (HRs) for total and cause-specific mortality were estimated by Cox regression models, using follow-up time as the time scale and allowing for time-variable diabetes status after adjusting for age, socioeconomic status, use of health services, and anthropometric and lifestyle variables. RESULTS: In multivariable-adjusted models, the HR for all-cause mortality was 3.28 (95% CI: 2.86-3.75) in women with vs. without diabetes. The impact of diabetes on mortality was higher in rural vs. urban areas (HR: 4.72 vs. 2.98, respectively). HRs were 1.57 and 23.44 for cancer and renal disease mortality, respectively. CONCLUSION: In women with healthcare coverage in Mexico, the magnitude of the association between diabetes and all-cause mortality was higher than that observed in high-income countries, but less than what has previously been reported for Mexico. Such elevated mortality suggests a lack of adequate access to quality diabetes care in the population despite comprehensive healthcare coverage.
AIMS: In Mexico City, the mortality rate among patients with diabetes appears to be four times that of people without diabetes. Our study aimed to refine analyses of the impact of diabetes on mortality in a large cohort of women from different areas in Mexico with healthcare insurance. METHODS: Our study followed 111,299 women with comprehensive healthcare coverage from the Mexican Teachers' Cohort. After a median follow-up of 7.8years, 5514 (5%) prevalent self-reported diabetes cases and 4023 incident cases were identified, while deaths were identified through employers' databases and next-of-kin reports, with dates and causes of death for 1121 women obtained from mortality databases. Hazard ratios (HRs) for total and cause-specific mortality were estimated by Cox regression models, using follow-up time as the time scale and allowing for time-variable diabetes status after adjusting for age, socioeconomic status, use of health services, and anthropometric and lifestyle variables. RESULTS: In multivariable-adjusted models, the HR for all-cause mortality was 3.28 (95% CI: 2.86-3.75) in women with vs. without diabetes. The impact of diabetes on mortality was higher in rural vs. urban areas (HR: 4.72 vs. 2.98, respectively). HRs were 1.57 and 23.44 for cancer and renal diseasemortality, respectively. CONCLUSION: In women with healthcare coverage in Mexico, the magnitude of the association between diabetes and all-cause mortality was higher than that observed in high-income countries, but less than what has previously been reported for Mexico. Such elevated mortality suggests a lack of adequate access to quality diabetes care in the population despite comprehensive healthcare coverage.
Authors: B E Ainsworth; W L Haskell; M C Whitt; M L Irwin; A M Swartz; S J Strath; W L O'Brien; D R Bassett; K H Schmitz; P O Emplaincourt; D R Jacobs; A S Leon Journal: Med Sci Sports Exerc Date: 2000-09 Impact factor: 5.411
Authors: Carlos A Aguilar-Salinas; Rosalba Rojas; Francisco J Gómez-Pérez; Eduardo García; Victoria Valles; Juan Manuel Ríos-Torres; Aurora Franco; Gustavo Olaiz; Jaime Sepúlveda; Juan A Rull Journal: Am J Med Date: 2002-11 Impact factor: 4.965
Authors: Edward Giovannucci; David M Harlan; Michael C Archer; Richard M Bergenstal; Susan M Gapstur; Laurel A Habel; Michael Pollak; Judith G Regensteiner; Douglas Yee Journal: Diabetes Care Date: 2010-07 Impact factor: 19.112
Authors: Norma C Segovia-Gamboa; Martha E Rodríguez-Arellano; Andrés Muñoz-Solís; Jorge E Retana-Jiménez; Germán Vargas-Ayala; Julio Granados; Marisela Jiménez-Sánchez; Carmen Sanchez-Torres Journal: Acta Diabetol Date: 2018-10-10 Impact factor: 4.280
Authors: William G Herrington; Jesus Alegre-Díaz; Rachel Wade; Louisa Gnatiuc; Raúl Ramirez-Reyes; Michael Hill; Martha Solano-Sánchez; Colin Baigent; Sarah Lewington; Rory Collins; Roberto Tapia-Conyer; Richard Peto; Pablo Kuri-Morales; Jonathan R Emberson Journal: Lancet Diabetes Endocrinol Date: 2018-03-19 Impact factor: 44.867